Judge Mulls Revival Of Nexium Pay-For-Delay Row

Law360, New York (March 7, 2014, 6:37 PM EST) -- A Massachusetts federal judge on Friday requested further briefing on whether he should reconsider portions of an order that granted victories to drugmakers Ranbaxy Inc. and Teva Pharmaceutical Industries Ltd. in a pay-for-delay class action involving the heartburn drug Nexium.

U.S. District Judge William G. Young denied a flurry of motions for reconsideration stemming from his multi-pronged Feb. 12 order, but laid out an expedited briefing schedule with regard to a pair of direct purchaser class plaintiffs' motions to give the Teva and Ranbaxy summary judgment...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.